News
Click here for news in Danish.
September 24, 2021 | Company Announcements
Bavarian Nordic’s COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament September 16, 2021 | Managers' Transactions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchSeptember 10, 2021 | Managers' Transactions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchSeptember 08, 2021 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseSeptember 01, 2021 | Company Announcements
Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine CandidateAugust 25, 2021 | Company Announcements
Bavarian Nordic Announces First Half 2021 Results August 23, 2021 | Company Announcements
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster VaccineAugust 23, 2021 | Company Announcements
Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine August 09, 2021 | Company Announcements
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine June 11, 2021 | Press Releases
Bavarian Nordic Assists Public Health England in Response to New Cases of MonkeypoxJune 10, 2021 | Managers' Transactions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchJune 10, 2021 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseJune 07, 2021 | Press Releases
Updated Recommendations from the World Health Organization Further Support Use of Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic June 02, 2021 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back ProgramMay 27, 2021 | Company Announcements
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme ObligationsMay 27, 2021 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Three Months of 2021May 27, 2021 | Company Announcements
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany May 17, 2021 | Press Releases
Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic Supports World Health Organization in Efforts to Prevent Spread of Ebola in West Africa May 12, 2021 | Managers' Transactions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMay 07, 2021 | Press Releases
U.S. Government Exercises Option for Supply of Additional Smallpox Vaccines from Bavarian Nordic April 29, 2021 | Company Announcements
Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 VariantsApril 20, 2021 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021April 17, 2021 | Managers' Transactions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchApril 06, 2021 | Company Announcements
Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines March 29, 2021 | Company Announcements
Bavarian Nordic A/S – Notice Convening Ordinary General Meeting